On Monday, Rovi Corporation (NASDAQ:ROVI)’s shares declined -4.57% to $16.70.
Rovi Corporation (ROVI) issued the following statement regarding a recommendation from leading independent proxy advisory firm Egan-Jones that Rovi’s stockholders vote “FOR” all seven of Rovi’s director nominees on the BLUE proxy card at the Company’s forthcoming 2015 Annual Meeting on May 13, 2015:
They are happy that this independent proxy advisory firm has recommended in favor of all of Rovi’s highly qualified director nominees. Their Board has taken deliberate actions to transform Rovi’s leadership, strategy and structure, and they are now well-positioned to leverage their compelling patent portfolio and continue developing next-generation products to drive sustainable returns. Egan-Jones’ recommendation squarely rejects the notion that Engaged Capital’s director nominees will improve the Rovi Board, and validates their concern that disrupting their leadership team would put substantial stockholder value at risk, especially at this point in time ahead of our Big-4 license renewals.
Rovi Corporation provides integrated solutions for the discovery and personalization of digital entertainment to service providers and consumer electronics (CE) industry worldwide.
Mast Therapeutics Inc (NYSEMKT:MSTX)’s shares dropped -4.69% to $0.510.
Mast Therapeutics Inc (MSTX) stated financial results for the quarter ended March 31, 2015.
First Quarter 2015 Operating Results
The Company’s net loss for the first quarter of 2015 was $9.6 million, or $0.06 per share (basic and diluted), contrast to a net loss of $6.4 million, or $0.06 per share (basic and diluted), for the same period in 2014.
Research and development (R&D) expenses for the first quarter of 2015 were $6.0 million, an enhance of $1.7 million, or 41%, contrast to $4.3 million for the same period in 2014. The enhance was primarily due to enhances of $1.2 million in external clinical study fees and expenses and $0.4 million in external nonclinical study fees and expenses. Raised enrollment in the EPIC study was the primary driver of the enhance in R&D expenses.
Balance Sheet Highlights
As of March 31, 2015, the Company had cash, cash equivalents and investment securities totaling $49.9 million. Stockholders’ equity amounted to $50.1 million as of March 31, 2015.
Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases. The companys lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure.
At the end of Monday’s trade, TrueCar Inc (NASDAQ:TRUE)‘s shares dipped -4.25% to $13.51.
TrueCar Inc (TRUE) declared that TrueCar administration will take part in the following forthcoming investor conferences:
B. Riley & Co.’s 16th Annual Investor Conference to be held May 12 — 14, 2015 at the Loews Hollywood Hotel in Los Angeles, California. TrueCar is planned to present on Wednesday, May 13, 2015, at 9:30 a.m. PT / 12:30 p.m. ET.
J.P. Morgan’s 43rd Annual Technology, Media and Telecom Conference to be held May 18 — 20, 2015 at the Westin Waterfront Hotel in Boston, Massachusetts. TrueCar is planned to present on Monday, May 18, 2015, at 8:20 a.m. PT / 11:20 a.m. ET.
Cowen and Co.’s 43rd Annual Technology, Media & Telecom Conference to be held May 27 — 28, 2015 at The New York Palace Hotel in New York City. TrueCar is planned to present on Wednesday, May 27, 2015, at 11:45 a.m. PT / 2:45 p.m. ET.
TrueCar, Inc. operates as an Internet-based information, technology, and communication services company. The company operates its platform on the TrueCar Website and TrueCar mobile applications. It also customizes and operates its platform for its affinity group marketing partners, counting financial institutions, membership-based organizations, and employee buying programs for large enterprises.
Sanchez Energy Corp (NYSE:SN), ended its Monday’s trading session with -4.03% loss, and closed at $12.39.
Sanchez Energy Corp (SN) The Board determined Mr. Carney to be independent under the rules of the New York Stock Exchange (“NYSE”) and qualified to serve on the Audit Committee, the Nominating and Corporate Governance Committee and the Compensation Committee of the Board under the rules of the NYSE and the Securities and Exchange Commission, to which committees Mr. Carney was designated co presently with his appointment as director.
Sanchez Energy Corporation, an independent exploration and production company, focuses on the acquisition, exploration, and development of unconventional oil and natural gas resources in the onshore U.S. Gulf Coast.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
